Company
Laigo Bio
- Biotech
- Headquarters:
- Utrecht, The Netherlands
- Location:
- AL (Utrecht, Netherlands)
Description
Laigo Bio develops SureTACs, bispecific protein-degradation therapeutics that remove disease-driving cell-surface proteins for oncology and expanding indications including immunology and neuroinflammation.
Related
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics modulating the Wiskott–Aldrich Syndrome protein for oncology and…
ProfluentProfluent builds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other…
Trained Therapeutix DiscoveryTrained Therapeutix Discovery develops modular nanobiologic therapeutics that regulate trained immunity for applications in cancer and…
ResQ Biotech Private CompanyDevelops a living-cell discovery platform that biosynthesizes and functionally screens macrocyclic libraries to identify therapeutics that…
HAYA TherapeuticsHAYA Therapeutics develops RNA-guided therapies that reprogram disease-driving cell states to reverse pathology, producing lncRNA-targeting…
Editas Medicine ($EDIT)Editas Medicine develops CRISPR-based genomic medicines intended to revise, remove, or replace DNA for people living with serious diseases…
Lumen BioscienceLumen Bioscience develops oral biologic drugs using spirulina-based technology to produce and deliver therapeutic proteins for diseases…
UTHealth HoustonUTHealth Houston operates a molecular medicine research institute translating studies in genetics, cancer, immunology, imaging,…
Generate:BiomedicinesGenerate:Biomedicines designs and engineers therapeutic proteins and cell therapies by combining machine learning with biological…
XENOTHERAXENOTHERA develops glyco-humanized antibody therapeutics and related immunological treatments for clinical use, pursuing products in…
Constructive BioConstructive Bio designs and manufactures new-to-nature proteins and enables scalable production of therapeutics and advanced materials…
RS Research Inc.Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for…